The iToBoS project is presented by the Girona Science and Technology Park (ParcUdG) as an international research project for the early detection of melanoma.
The Vicorob research group coordinates this international research project, led by Prof. Rafael García, with the aim of creating a tool for the early detection of skin tumors. Funded by the European Union's Horizon 2020 research and innovation program, the iToBoS project will develop a body scanner that will carry out a comprehensive assessment of patients and allow different types of skin cancer to be detected in an advanced and personalized way. The project has a total budget of 12 million euros and will end in 2025.
Among the plans is to devise an artificial intelligence system capable of integrating information from different sources: from images of the patient's skin surface, their demographics and medical records to information genomics through a saliva sample. In addition, the research will allow the development of an artificial intelligence system to assist health professionals in carrying out a comprehensive diagnosis of skin cancer personalized for each patient. The breakthrough is expected to help improve detection rates and generate highly individualized diagnoses.
The tool is based on the latest trends in artificial intelligence to combine data already available and obtained with currently existing technologies (dermatoscopic images) with information acquired from the innovative iToBoS scanner. In addition, the algorithms will integrate additional patient data - medical history, genomics, age, sex... - to evaluate the freckles according to the characteristics of each patient.
The ParcUdG is an economic engine and generation of business talent aimed at being the fundamental agent for promoting the economic development of the regions of Girona based on knowledge and technology. It is a space for collaboration, an environment to support research, development and innovation in all areas, especially those related to information technology and medical and biotechnological research.
Read more at ParcUdG.